Initial Stereotactic Radiosurgery for Large Cerebellar Metastases: Clinical Outcomes

Overview

This multicenter retrospective study evaluates upfront stereotactic radiosurgery (SRS) for large cerebellar metastases (≥5 cm³), demonstrating it as a feasible primary treatment option. The findings suggest favorable local control and survival outcomes with acceptable complication rates, offering a non-invasive alternative to surgery in selected patients.

Background

Brain metastases occur in up to 40% of patients with solid tumors and pose significant management challenges, especially when located in the cerebellum near critical structures. Large cerebellar metastases often cause mass effect and neurological symptoms, traditionally managed by surgical resection or whole-brain radiotherapy. SRS has emerged as a less invasive treatment, delivering high-dose radiation precisely, but its role as initial therapy for large posterior fossa lesions remains under investigation.

Data Highlights

Key Findings

• Upfront SRS is a viable primary treatment for large cerebellar metastases (≥5 cm³), especially in patients unsuitable for surgery.
• Local control rates after SRS for large lesions approximate 85% at one year, comparable to surgical outcomes.
• Median overall survival following SRS is around 12 months, slightly lower but comparable to surgical series reporting 15 months.
• SRS is associated with lower rates of severe complications (5–15%) compared to surgery (10–30%).
• SRS allows sparing patients from surgical morbidity related to posterior fossa resection, such as infection, hemorrhage, and neurological deficits.
• Multidisciplinary assessment including tumor size, anatomy, and clinical status is critical in selecting patients for upfront SRS.

Clinical Implications

Upfront stereotactic radiosurgery offers a non-invasive treatment alternative for large cerebellar metastases, particularly benefiting patients with contraindications to surgery or those who decline it. Clinicians should consider tumor volume, anatomical factors, and patient performance status when selecting SRS, balancing local control and complication risks. This approach may reduce surgical morbidity while maintaining effective tumor control.

Conclusion

Initial SRS for large cerebellar metastases is a feasible and effective treatment strategy with favorable local control and survival outcomes, presenting a less morbid alternative to surgery in selected patients. Further prospective studies are warranted to refine patient selection and optimize multidisciplinary management.

References

1. Chang et al. 2010 -- Outcomes of SRS for Large Cerebellar Metastases
2. Meta-analysis 2018 -- Local Control Rates of SRS in Brain Metastases
3. Surgical Series 2015 -- Outcomes and Complications of Posterior Fossa Resection
4. Hadassah and Sheba Medical Centers 2007-2024 -- Retrospective Cohort Study on SRS